City Therapeutics

Engineering the future of RNAi-based medicine

Cambridge, United States · Founded 2024 · $234.5M raised

Founded
2024
Business Model
B2B
Website
citytx.com
Total Funding
$234.5M
Last Round
$99.5M Series BJun 2026
Rounds
2

About

City Therapeutics is a Cambridge, MA-based clinical-stage biopharmaceutical company founded by RNAi pioneers to engineer next-generation small interfering RNA (siRNA) therapeutics. Its platform advances novel trigger molecules and extrahepatic delivery ligands to expand RNAi reach beyond the liver. Lead programs include CITY-FXI for thromboembolic diseases and CITY-RBP4 for Stargardt disease, backed by over $230 million in financing.

Summary

City Therapeutics is a Biotech company based in Cambridge, United States, founded in 2024. It has raised $234.5M in total across 2 rounds, most recently a $99.5M Series B round in Jun 2026. Investors include Viking Global, ARCH Venture Partners and Sofinnova Investments.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BJun 2026
$99.5M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

City Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/city-therapeutics"><img src="https://indexed.vc/api/badge/company/city-therapeutics" alt="City Therapeutics on Indexed.vc" width="260" height="76" /></a>